Bettina Budeus

820 total citations
39 papers, 434 citations indexed

About

Bettina Budeus is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Bettina Budeus has authored 39 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Genetics. Recurrent topics in Bettina Budeus's work include T-cell and B-cell Immunology (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Bettina Budeus is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Bettina Budeus collaborates with scholars based in Germany, United States and Spain. Bettina Budeus's co-authors include Daniel Hoffmann, Ralf Küppers, Marc Seifert, Martina Przekopowitz, Ángel J. Picher, Dominik Heider, Alberto Díaz‐Talavera, María I. Martínez-Jiménez, Daniela Weber and Armin Schneider and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Bettina Budeus

32 papers receiving 427 citations

Peers

Bettina Budeus
Sichen Li China
Suzu Igarashi United States
Sabrina Imam United States
S. Khan Canada
I Krebs Germany
Bettina Budeus
Citations per year, relative to Bettina Budeus Bettina Budeus (= 1×) peers Ichiro Nishikata

Countries citing papers authored by Bettina Budeus

Since Specialization
Citations

This map shows the geographic impact of Bettina Budeus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Budeus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Budeus more than expected).

Fields of papers citing papers by Bettina Budeus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Budeus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Budeus. The network helps show where Bettina Budeus may publish in the future.

Co-authorship network of co-authors of Bettina Budeus

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Budeus. A scholar is included among the top collaborators of Bettina Budeus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Budeus. Bettina Budeus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lollies, Anna, M. Schneider, Patricia Johansson, et al.. (2025). Common origin and somatic mutation patterns of composite lymphomas and leukemias. Leukemia. 39(8). 1960–1971.
2.
Budeus, Bettina, et al.. (2025). Roxadustat enhances inflammation and metabolic reprogramming in human leukocytes by affecting oxygen sensing. The Journal of Immunology. 214(12). 3321–3331.
3.
Dubler, Simon, Christoph Lichtenstern, Thorsten Brenner, et al.. (2025). Implications for the diagnosis of aspiration and aspergillosis in critically ill patients with detection of galactomannan in broncho-alveolar lavage fluids. Scientific Reports. 15(1). 1997–1997. 1 indexed citations
4.
Jendrossek, Verena, et al.. (2025). Generating Free-floating Normal Human Epithelial-Fibroblast Spheroid Co-Cultures. Journal of Visualized Experiments.
5.
Budeus, Bettina, Claudia A. Dumitru, Mathias Schmidt, et al.. (2025). Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotype. Cellular and Molecular Immunology. 22(5). 527–540. 1 indexed citations
6.
Braun, Annika, et al.. (2024). Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells. Frontiers in Oncology. 14. 1406268–1406268. 6 indexed citations
7.
Budeus, Bettina, Saskia Ting, Deniz Kanber, et al.. (2024). In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies. Cell Death and Disease. 15(12). 905–905.
8.
Budeus, Bettina, et al.. (2024). Matrix-free human lung organoids derived from induced pluripotent stem cells to model lung injury. Stem Cell Research & Therapy. 15(1). 468–468. 6 indexed citations
9.
Metz, K., et al.. (2023). Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma. Journal of Oncology. 2023. 1–22. 2 indexed citations
10.
Schäfer, Simon, Bettina Budeus, Sieglinde Angermüller, et al.. (2023). The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia. EMBO Reports. 24(8). e56420–e56420. 4 indexed citations
11.
Dubler, Simon, Markus A. Weigand, Thorsten Brenner, et al.. (2023). Impact of Invasive Pulmonary Aspergillosis in Critically Ill Surgical Patients with or without Solid Organ Transplantation. Journal of Clinical Medicine. 12(9). 3282–3282. 4 indexed citations
12.
Budeus, Bettina, et al.. (2023). Human IgM–expressing memory B cells. Frontiers in Immunology. 14. 1308378–1308378. 15 indexed citations
13.
Budeus, Bettina, et al.. (2023). Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts. Frontiers in Immunology. 14. 1270493–1270493. 9 indexed citations
14.
Hasenberg, Mike, Bernd Walkenfort, Marc Seifert, et al.. (2023). Fc N‐glycosylation of autoreactive Aβ antibodies as a blood‐based biomarker for Alzheimer's disease. Alzheimer s & Dementia. 19(12). 5563–5572. 11 indexed citations
15.
Küppers, Ralf, Bettina Budeus, Sylvia Hartmann, & Martin‐Leo Hansmann. (2023). Clonal composition and differentiation stage of human CD30+ B cells in reactive lymph nodes. Frontiers in Immunology. 14. 1208610–1208610. 4 indexed citations
16.
Budeus, Bettina, Ludger Sellmann, Florian Murke, et al.. (2021). Systematic memory B cell archiving and random display shape the human splenic marginal zone throughout life. The Journal of Experimental Medicine. 218(4). 21 indexed citations
17.
Johansson, Patricia, Ludger Klein‐Hitpaß, Bettina Budeus, et al.. (2020). Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing. Cancers. 12(4). 986–986. 17 indexed citations
18.
Picher, Ángel J., Félix Hernández, Bettina Budeus, Eduardo Soriano, & Jesús Ávila. (2018). Human Brain Single Nucleotide Polymorphism: Validation of DNA Sequencing. Journal of Alzheimer s Disease Reports. 2(1). 103–109. 1 indexed citations
19.
Lange, Anja, Steffen Jost, Dominik Heider, et al.. (2015). AmpliconDuo: A Split-Sample Filtering Protocol for High-Throughput Amplicon Sequencing of Microbial Communities. PLoS ONE. 10(11). e0141590–e0141590. 38 indexed citations
20.
Qin, Bo, Bettina Budeus, Liang Cao, et al.. (2012). The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir. Antiviral Research. 97(2). 93–100. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026